O, C., M, B., F, C., N, J., N, D., & B, G. (2022). Isotretinoin: Reasserting its public health value at the population level, addressing potential neuropsychiatric risk at the individual level. The British journal of dermatology, 187(5), 831. https://doi.org/10.1111/bjd.21764
Chicago Style (17th ed.) CitationO, Chosidow, Beylot-Barry M, Corgibet F, Jouan N, Dupin N, and Guillot B. "Isotretinoin: Reasserting Its Public Health Value at the Population Level, Addressing Potential Neuropsychiatric Risk at the Individual Level." The British Journal of Dermatology 187, no. 5 (2022): 831. https://doi.org/10.1111/bjd.21764.
MLA (9th ed.) CitationO, Chosidow, et al. "Isotretinoin: Reasserting Its Public Health Value at the Population Level, Addressing Potential Neuropsychiatric Risk at the Individual Level." The British Journal of Dermatology, vol. 187, no. 5, 2022, p. 831, https://doi.org/10.1111/bjd.21764.